Showing 1–20 of 57 results
Amyloidosis PBMC
Amyloidosis PBMC samples are isolated from donors with clinically confirmed amyloidosis. Ideal for studying immune system involvement, plasma cell dysregulation, and cellular responses to amyloid protein deposition.
Amyloidosis Plasma
Amyloidosis Plasma is collected from donors with clinically confirmed amyloidosis. Useful for analyzing circulating amyloid precursors, inflammatory cytokines, and biomarkers of systemic protein misfolding.
Amyloidosis Serum
Amyloidosis Serum is collected from donors with clinically confirmed amyloidosis. Ideal for detecting light chains, amyloid-associated proteins, and tracking disease progression in systemic amyloidosis.
Amyloidosis Whole Blood
Amyloidosis Whole Blood is collected from donors with clinically confirmed amyloidosis. Suitable for genomic and transcriptomic studies to explore underlying mechanisms of protein misfolding and immune response.
Antiphospholipid Syndrome PBMC
Antiphospholipid Syndrome PBMC is collected from donors with clinically confirmed antiphospholipid syndrome (APS). Ideal for investigating T and B cell function, autoantibody-producing cells, and immune dysregulation driving APS-associated thrombosis.
Antiphospholipid Syndrome Plasma
Antiphospholipid Syndrome Plasma is collected from donors with clinically confirmed antiphospholipid syndrome (APS). Suitable for studying prothrombotic markers, autoantibodies, and immune system dysregulation associated with APS-related clotting disorders.
Antiphospholipid Syndrome Serum
Amyloidosis Serum is collected from donors with clinically confirmed amyloidosis. Ideal for detecting light chains, amyloid-associated proteins, and tracking disease progression in systemic amyloidosis.
Antiphospholipid Syndrome Whole Blood
Amyloidosis Whole Blood is collected from donors with clinically confirmed amyloidosis. Suitable for genomic and transcriptomic studies to explore underlying mechanisms of protein misfolding and immune response.
Chronic Granulomatous Disease Plasma
Chronic Granulomatous Disease Plasma samples are collected from donors diagnosed with chronic granulomatous disease (CGD). Suitable for profiling inflammatory cytokines, oxidative stress markers, and soluble immune mediators linked to infection susceptibility and granuloma formation.
Chronic Granulomatous Disease Serum
Chronic Granulomatous Disease Serum samples are derived from donors with confirmed chronic granulomatous disease (CGD). Useful for analyzing immune dysregulation, infection-related biomarkers, and systemic indicators of chronic inflammation.
Chronic Granulomatous Disease Whole Blood
Chronic Granulomatous Disease Whole Blood samples are obtained from donors with clinically and genetically diagnosed chronic granulomatous disease (CGD). Valuable for gene expression analysis, neutrophil function studies, and comprehensive immune profiling in phagocytic disorders.
Essential Thrombocythemia PBMC
Essential Thrombocythemia PBMC samples are collected from clinically confirmed essential thrombocythemia (ET) donors and cryopreserved . These ET PBMCs are ideal for studying immune dysregulation and cytokine profiling.
Essential Thrombocythemia Plasma
Essential Thrombocythemia Plasma – Cryopreserved human plasma collected from clinically confirmed essential thrombocythemia (ET) donors. Essential Thrombocythemia plasma is ideal for inflammation studies, cytokine profiling, and biomarker research.
Essential Thrombocythemia Serum
Essential Thrombocythemia Serum – Human serum samples collected from clinically confirmed Essential Thrombocythemia donors. Ideal for dermatology, cytokine profiling, and inflammation-related research.
Essential Thrombocythemia Whole Blood
Essential Thrombocythemia Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Essential Thrombocythemia (ET). Ideal for dermatology, immunology, and inflammation-based research.
Graft-Versus-Host Disease PBMC
Graft-versus-Host Disease PBMC samples are isolated from donors with clinically diagnosed graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell transplantation. Ideal for studying T cell–mediated immune responses, allo-reactivity, and mechanisms of tissue injury in acute and chronic GvHD.
Graft-Versus-Host Disease Plasma
Graft-versus-Host Disease Plasma samples are collected from donors experiencing graft-versus-host disease (GVHD). Suitable for analyzing cytokines, chemokines, and soluble biomarkers such as ST2 and Reg3α that are associated with disease severity, organ involvement, and therapeutic response.
Graft-Versus-Host Disease Serum
Graft-versus-Host Disease Serum samples are derived from donors with confirmed graft-versus-host disease (GVHD). Useful for evaluating immune dysregulation, inflammatory mediators, and potential predictive markers of treatment outcomes and relapse risk.
Graft-Versus-Host Disease Whole Blood
Graft-versus-Host Disease Whole Blood samples are obtained from donors with clinically diagnosed graft-versus-host disease (GVHD). Valuable for gene expression studies, immune cell profiling, and identifying molecular pathways involved in transplant-related complications.
Idiopathic Thrombocytopenia Purpura Whole Blood
Idiopathic Thrombocytopenia Purpura Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Idiopathic Thrombocytopenic Purpura (ITP). Ideal for dermatology, immunology, and inflammation-based research.